Literature DB >> 24769455

Locomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis.

Morgane Thomsen1.   

Abstract

Muscarinic cholinergic receptors are currently receiving renewed interest as viable targets for treating various psychiatric disorders. Dopaminergic and muscarinic systems interact in complex ways. The goal of this study was to quantify the interaction between a systemically administered psychomotor stimulant and muscarinic antagonist at the behavioral level. Through isobolographic analysis of locomotor activity data, we assessed the effects of three cocaine/scopolamine mixtures in terms of deviation from simple dose addition (additivity), at four effect levels. All three mixtures produced some more-than-additive (synergistic) effects, as lower doses were needed to produce the given effects relative to the calculated effect of additive doses. A mixture with comparable contributions from cocaine and scopolamine produced significantly more-than-additive effects at all but the lowest effect level examined. A mostly-cocaine mixture was more-than-additive only at low effect levels, whereas a mostly-scopolamine mixture produced effects more consistent with additivity, with only the highest effect level barely reaching significant synergism. Our study confirms and quantifies previous findings that suggested synergistic effects of stimulants and muscarinic antagonists. The synergism implies that cocaine and scopolamine stimulate locomotor activity through nonidentical pathways, and was most pronounced for a mixture containing cocaine and scopolamine in comparable proportions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24769455      PMCID: PMC4090251          DOI: 10.1097/FBP.0000000000000043

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  49 in total

1.  Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.

Authors:  Gianluigi Tanda; Aaron L Ebbs; Theresa A Kopajtic; Lyn M Elias; Bettye L Campbell; Amy H Newman; Jonathan L Katz
Journal:  J Pharmacol Exp Ther       Date:  2007-01-25       Impact factor: 4.030

2.  Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.

Authors:  J L Katz; S Izenwasser; R H Kline; A C Allen; A H Newman
Journal:  J Pharmacol Exp Ther       Date:  1999-01       Impact factor: 4.030

3.  Interactions between central cholinergic agents and amphetamine in mice.

Authors:  J H Mennear
Journal:  Psychopharmacologia       Date:  1965-02-15

4.  Study on the excitation induced by amphetamine, cocaine and alpha-methyltryptamine.

Authors:  E Galambos; A K Pfeifer; L György; J Molnár
Journal:  Psychopharmacologia       Date:  1967

5.  Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.

Authors:  Morgane Thomsen; P Jeffrey Conn; Craig Lindsley; Jürgen Wess; Joon Y Boon; Brian S Fulton; Anders Fink-Jensen; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2009-12-08       Impact factor: 4.030

6.  Differential effects of trihexyphenidyl on place preference conditioning and locomotor stimulant activity of cocaine and methamphetamine.

Authors:  K Shimosato; S Watanabe; S Kitayama
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-07       Impact factor: 3.000

7.  Age-dependent effects of scopolamine on avoidance, locomotor activity, and rearing.

Authors:  R H Bauer
Journal:  Behav Brain Res       Date:  1982-07       Impact factor: 3.332

8.  Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses.

Authors:  M Morelli; S Fenu; A Cozzolino; A Pinna; A Carta; G Di Chiara
Journal:  Neuroscience       Date:  1993-04       Impact factor: 3.590

Review 9.  Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.

Authors:  P Jeffrey Conn; Carrie K Jones; Craig W Lindsley
Journal:  Trends Pharmacol Sci       Date:  2009-02-07       Impact factor: 14.819

10.  Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.

Authors:  Sarah Threlfell; Tatjana Lalic; Nicola J Platt; Katie A Jennings; Karl Deisseroth; Stephanie J Cragg
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

View more
  3 in total

1.  Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.

Authors:  Lauren Joseph; Morgane Thomsen
Journal:  Behav Brain Res       Date:  2017-04-22       Impact factor: 3.332

Review 2.  Application of dose-addition analyses to characterize the abuse-related effects of drug mixtures.

Authors:  Michelle R Doyle; Brenda M Gannon; Melson P Mesmin; Gregory T Collins
Journal:  J Exp Anal Behav       Date:  2022-02-10       Impact factor: 2.215

3.  Scopolamine Impairs Spatial Information Recorded With "Miniscope" Calcium Imaging in Hippocampal Place Cells.

Authors:  Dechuan Sun; Ranjith Rajasekharan Unnithan; Chris French
Journal:  Front Neurosci       Date:  2021-03-19       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.